PolyPeptide Group: Provisional interim result of the public tender offer of Samsung Biologics Co., Ltd.

PolyPeptide Group / Key word(s): Tender Offer PolyPeptide Group: Provisional interim result of the public tender offer of Samsung Biologics Co., Ltd. 13-Oct-2026 / 07:10 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. ══════════════════════════════════════════════════════════════════════════ Media Release — ad hoc announcement pursuant to Art. 53 LR Provisional interim result of the public tender offer of Samsung Biologics Co., Ltd. Baar, Switzerland, 13 October 2026 — Samsung Biologics Co., Ltd. ("Samsung Biologics"), through its direct subsidiary Samsung Peptide AG ("Samsung Peptide"), today published the provisional interim result of its public tender offer (the "Offer") for all publicly held registered shares of PolyPeptide Group AG ("PolyPeptide") (SIX: PPGN). The main offer period of the Offer ended on 12 October 2026, at 4:00 p.m. Swiss time. According to the provisional interim result as published by Samsung Peptide, • the participation of Samsung Peptide and the persons acting in concert with Samsung Peptide amounts to 29,123,892 PolyPeptide shares in aggregate, corresponding to 87.92%